GO:0141038 phosphatidylinositol 3-kinase activator activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0141038 phosphatidylinositol 3-kinase activator activity describes a molecular function in which a protein binds to and increases the catalytic activity of a phosphatidylinositol 3-kinase (PI3K).
• This activator activity is a upstream control point of the PI3K/AKT/mTOR signaling axis, a pathway repeatedly implicated in cancer, metabolic disease, and tissue remodeling [1,2].
• Activators can act on class I, class II, and class III PI3K enzymes, and the functional outcome depends on which PI3K isoform is engaged and in which cellular context [5,7].
• The PI3K/AKT pathway downstream of PI3K activation regulates survival, proliferation, glucose uptake, protein synthesis, and autophagy initiation [1,6].
• Dysregulated PI3K activator function has been linked to gastric cancer, corneal epithelial pathology, skeletal muscle atrophy, and hepatic glucocorticoid responses [1,2,4,5].
• CRISPR knockout, point-mutation, knock-in, and overexpression models are the core tools for causally testing whether a candidate activator gene drives PI3K-dependent phenotypes [1,2].
Description
GO:0141038 phosphatidylinositol 3-kinase activator activity is a molecular function term that captures the ability of a protein to bind to a phosphatidylinositol 3-kinase (PI3K) and increase its enzymatic activity. PI3K enzymes phosphorylate phosphoinositides at the 3-position of the inositol ring, generating lipid second messengers that recruit downstream effectors such as AKT [1,2]. Because PI3K signaling sits at the center of growth factor, insulin, and immune receptor responses, proteins that activate PI3K are positioned as critical nodes in signal transduction [1,3]. Researchers study this term because PI3K activator activity is not merely a housekeeping function; it is a regulated, context-dependent event that determines the amplitude and duration of PI3K/AKT/mTOR signaling [1,2]. In cancer, excessive PI3K pathway activity is a common oncogenic driver, and activator proteins can contribute to pathway hyperactivation. In metabolic and musculoskeletal contexts, PI3K activation downstream of IGF-1/IGF-1R supports protein synthesis and opposes atrophy. In the liver, class III PI3K function intersects with glucocorticoid receptor stability and transcriptional output. This article integrates the QuickGO definition of GO:0141038 with verified PubMed literature to describe the mechanism, key genes, disease relevance, and experimental methods used to interrogate phosphatidylinositol 3-kinase activator activity [1,2,5,7]. It is intended for researchers designing CRISPR screens, mechanistic cell biology studies, or translational programs targeting the PI3K axis [1,2].
phosphatidylinositol 3-kinase activator activity At A Glance
| GO ID | GO:0141038 |
|---|---|
| GO term | phosphatidylinositol 3-kinase activator activity |
| Ontology | molecular_function |
| Synonym | none listed in QuickGO |
| Definition | Binds to and increases the activity of a phosphatidylinositol 3-kinase (PI3K). |
| Major function | Positive regulation of PI3K catalytic activity, leading to increased 3-phosphoinositide production and downstream AKT/mTOR signaling [1,2]. |
| Pathway context | PI3K/AKT/mTOR signaling axis, which controls survival, proliferation, metabolism, and autophagy [1,6]. |
| Representative PI3K classes | Class I, class II, and class III PI3K enzymes can be subject to activator regulation [5,7]. |
| Disease relevance | Cancer, metabolic and muscle atrophy conditions, corneal epithelial disorders, and hepatic glucocorticoid responses [1,2,4,5]. |
| Research methods | CRISPR KO/point-mutation/knock-in/overexpression, phospho-AKT immunoblotting, lipid kinase assays, and pathway inhibitors [1,2,8]. |
What Is GO:0141038?
In our own words, GO:0141038 phosphatidylinositol 3-kinase activator activity is a molecular function in which a protein physically binds to a phosphatidylinositol 3-kinase and increases that enzyme's catalytic activity. The term is defined by the activator's effect on PI3K, not by the activator's own enzymatic activity; the protein may or may not have additional catalytic functions [1,2]. This function is upstream of the lipid products generated by PI3K and therefore upstream of AKT and mTOR signaling events [1,2].
Why Is phosphatidylinositol 3-kinase activator activity Important in Cell Biology?
Phosphatidylinositol 3-kinase activator activity is important because it defines a regulatory entry point into one of the most frequently dysregulated signaling networks in human disease [1,2]. By binding and stimulating PI3K, activator proteins can amplify PI3K/AKT/mTOR output without necessarily being mutated themselves, making them attractive nodes for mechanistic and therapeutic investigation [1,2]. Understanding this activity helps explain how growth factors, insulin, exercise, and stress signals are translated into changes in cell survival, metabolism, and gene expression [3,4,5].
• Controls the amplitude of PI3K/AKT/mTOR signaling, a central growth and survival pathway [1,2].
• Links extracellular cues such as insulin and IGF-1 to intracellular lipid second messenger production [3,4].
• Contributes to cancer phenotypes when PI3K pathway activation is excessive.
• Modulates skeletal muscle protein synthesis and atrophy in response to exercise and IGF-1.
• Influences hepatic glucocorticoid receptor stability and transcriptional activity via class III PI3K.
• Intersects with autophagy initiation through PI3K-dependent phosphoinositide pools.
• Provides a mechanistic explanation for how non-enzymatic scaffold or adaptor proteins can drive signaling [1,2].
• Offers candidate targets for pharmacological modulation of PI3K-dependent diseases [1,8].
• Supports the design of CRISPR screens to identify causal PI3K activators [1,2].
• Helps interpret phospho-AKT and lipidomics readouts in pathway-focused studies [1,2].
Molecular Mechanism of phosphatidylinositol 3-kinase activator activity
Binding of the activator to PI3K
In simple terms: The activator protein first docks onto the PI3K enzyme.
The defining event of GO:0141038 is a physical interaction between an activator protein and a phosphatidylinositol 3-kinase. This binding can occur through modular domains that recognize PI3K subunits or through adaptor-mediated recruitment, and it is the prerequisite for increased catalytic output [1,2]. Because the term is defined by binding plus increased activity, assays that measure only interaction without kinase output are insufficient to annotate this function.
Allosteric or conformational activation of PI3K
In simple terms: Binding changes the shape of PI3K so it works faster.
Once bound, the activator increases PI3K catalytic activity, often by relieving autoinhibition or stabilizing an active conformation [1,7]. Structural studies of PI3K enzymes have revealed that distinct domains and regulatory inputs shape catalytic output, providing a framework for how activator binding could alter enzyme dynamics. The result is enhanced conversion of phosphoinositide substrates into 3-phosphorylated lipid products [1,2].
Generation of 3-phosphoinositide second messengers
In simple terms: Activated PI3K makes lipid signals that recruit other proteins.
Increased PI3K activity raises the levels of 3-phosphoinositides, which serve as membrane docking sites for effector proteins containing pleckstrin homology domains [1,2]. These lipid products propagate the signal to AKT and other downstream kinases, thereby converting the activator function into a broad cellular response [1,2]. In autophagy-related contexts, PI3K-generated phosphoinositides also contribute to autophagosome initiation machinery.
Downstream AKT/mTOR pathway engagement
In simple terms: The lipid signals switch on AKT and mTOR, which control growth and metabolism.
PI3K activation leads to AKT phosphorylation and subsequent mTOR pathway engagement, influencing survival, proliferation, protein synthesis, and metabolism [1,2]. In skeletal muscle, IGF-1/IGF-1R-PI3K/Akt signaling mediates exercise-induced protection against atrophy, illustrating how activator-driven PI3K output translates into tissue-level phenotypes. In the liver, class III PI3K activity supports glucocorticoid receptor stability and transcriptional activity, showing that PI3K-dependent outputs extend beyond canonical AKT signaling.
Feedback and context-dependent regulation
In simple terms: The pathway has brakes and depends on which cell type it is in.
PI3K/AKT/mTOR signaling is subject to feedback regulation, and the consequences of activator function depend on cell type, receptor context, and the specific PI3K class involved [1,2,5]. Pharmacological studies using natural compounds such as berberine have shown that modulating AMPK and PI3K/AKT can shift cancer cell phenotypes, underscoring the pathway's regulatory plasticity. Therefore, assigning GO:0141038 activity requires attention to the cellular and signaling context in which PI3K is being activated [1,2].
Key Genes Involved in GO:0141038 phosphatidylinositol 3-kinase activator activity
The following genes and proteins are representative components, regulators, or readouts of phosphatidylinositol 3-kinase activator activity and its downstream PI3K/AKT/mTOR signaling context.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PIK3CA | Encodes the catalytic p110 alpha subunit of class I PI3K | Frequently studied in cancer and a direct target of activator regulation |
| PIK3CB | Encodes the p110 beta catalytic subunit of class I PI3K | Relevant to growth factor and metabolic signaling contexts [1,2] |
| PIK3CD | Encodes the p110 delta catalytic subunit of class I PI3K | Studied in immune and inflammatory signaling contexts |
| PIK3C3 | Encodes class III PI3K (Vps34) | Linked to hepatic glucocorticoid receptor stability and autophagy-related processes [5,6] |
| PIK3C2A | Encodes class II PI3K C2 alpha | Structurally and functionally characterized in PI3K C2 alpha studies |
| AKT1 | Serine/threonine kinase downstream of PI3K | Central readout of PI3K activator activity [1,2] |
| AKT2 | AKT isoform involved in metabolic signaling | Used to assess PI3K pathway output in metabolic tissues [1,2] |
| MTOR | Kinase complex integrating PI3K/AKT signals | Downstream effector of PI3K activation |
| IGF1 | Growth factor ligand upstream of PI3K | Drives IGF-1R-PI3K/Akt signaling in muscle and other tissues |
| IGF1R | Receptor tyrosine kinase that recruits PI3K | Upstream activator context for PI3K signaling |
| INSR | Insulin receptor upstream of PI3K | Connects insulin signals to PI3K activation |
| IRS1 | Insulin receptor substrate adaptor | Scaffold that recruits PI3K to activated receptors |
| PTEN | Lipid phosphatase opposing PI3K | Negative regulator that sets the threshold for PI3K output |
| TSC1 | Component of the TSC complex upstream of mTOR | Integrates PI3K/AKT signals with mTOR regulation |
| TSC2 | Component of the TSC complex upstream of mTOR | Integrates PI3K/AKT signals with mTOR regulation |
| RPTOR | Component of mTORC1 | Downstream node of PI3K/AKT/mTOR signaling |
| BECN1 | Autophagy-related protein interacting with class III PI3K | Connects PI3K activity to autophagy initiation |
How Is phosphatidylinositol 3-kinase activator activity Regulated?
Phosphatidylinositol 3-kinase activator activity is regulated at multiple levels, including the availability of upstream receptor tyrosine kinase signals such as IGF-1/IGF-1R and insulin/INSR, the recruitment of adaptor proteins like IRS1, and the opposing action of lipid phosphatases such as PTEN [1,3,4]. Downstream feedback through mTOR and AKT can dampen or reshape PI3K output, and the specific PI3K class engaged influences which regulatory inputs dominate [1,5]. In hepatic cells, class III PI3K activity is connected to glucocorticoid receptor stability and transcriptional activity, illustrating tissue-specific regulatory wiring. Pharmacological modulation of AMPK and PI3K/AKT by compounds such as berberine further demonstrates that the pathway is responsive to metabolic and chemical cues.
phosphatidylinositol 3-kinase activator activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PIK3CA | Gastric cancer and other PI3K-driven malignancies | Knockout or point-mutation cell models with phospho-AKT readout |
| IGF1R | Skeletal muscle atrophy after myocardial infarction | Overexpression or knockout in muscle cell lines and mouse models |
| PIK3C3 | Hepatic glucocorticoid receptor stability and transcriptional activity | Knockout hepatocyte models with glucocorticoid response assays |
| AKT1 | Downstream effector in cancer and metabolic disease | Point-mutation knock-in to test activating variants [1,2] |
| PTEN | Negative regulator of PI3K signaling in cancer | Knockout models to elevate PI3K pathway output |
Cancer and oncogenic PI3K signaling
The PI3K/AKT/mTOR pathway is a major oncogenic axis, and targeting PI3K/AKT/mTOR alongside MAPK signaling is an active therapeutic strategy in gastric cancer. Activator proteins that increase PI3K activity can contribute to pathway hyperactivation and tumor cell survival, making GO:0141038 relevant to cancer mechanism studies. Natural compounds such as berberine have been shown to modulate AMPK and PI3K/AKT signaling with anti-cancer effects, highlighting the pathway's druggability.
Corneal epithelium and ocular surface biology
The PI3K/AKT signaling pathway plays important roles in corneal epithelium biology, where it influences cell survival, migration, and wound responses. Dysregulation of PI3K activator function could therefore affect corneal epithelial homeostasis and repair, although the specific activator proteins involved require further study.
Skeletal muscle atrophy and metabolic stress
IGF-1/IGF-1R-PI3K/Akt signaling mediates the beneficial effects of aerobic and resistance exercise in alleviating skeletal muscle atrophy in mice with myocardial infarction. This positions PI3K activator activity as a mechanistic node linking exercise, growth factor signaling, and muscle preservation.
Hepatic glucocorticoid responses
Class III PI3K promotes hepatic glucocorticoid receptor stability and transcriptional activity, connecting PI3K function to liver stress and metabolic gene regulation. This illustrates that phosphatidylinositol 3-kinase activator activity can influence nuclear receptor biology beyond canonical AKT signaling.
From phosphatidylinositol 3-kinase activator activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for PI3K activation? | CRISPR knockout cell line with phospho-AKT and lipid kinase readouts [1,2] |
| Does a specific residue mediate activator function? | Point-mutation knock-in of the candidate activator |
| Does an activating variant increase PI3K output? | Knock-in of the variant followed by pathway profiling [1,2] |
| Where does the activator localize relative to PI3K? | Tagged knock-in with fluorescence imaging |
| Does overexpression of the activator transform cells? | Stable overexpression in cancer cell lines [1,8] |
| Which genes modify PI3K-dependent phenotypes? | CRISPR library screening with pathway-selective selection |
How to Study the phosphatidylinositol 3-kinase activator activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Phospho-AKT immunoblotting | AKT phosphorylation status | Assessing PI3K pathway activation after gene perturbation [1,2] |
| Lipid kinase assay | PI3K catalytic activity | Direct biochemical validation of activator function [1,7] |
| CRISPR knockout screening | Gene requirement for pathway output | Discovery of PI3K activators or modifiers |
| CRISPR knock-in | Effect of specific variants | Testing point mutations in candidate activators |
| Overexpression | Gain-of-function effects | Testing whether a gene is sufficient to activate PI3K [1,8] |
| Fluorescence imaging | Subcellular localization | Visualizing activator-PI3K co-localization |
| Transcriptomics | Downstream gene expression changes | Confirming pathway engagement after perturbation [1,2] |
| Pharmacological inhibition | Pathway dependence | Using PI3K/AKT inhibitors to test causality [1,8] |
Phospho-AKT and pathway immunoblotting
Measuring phospho-AKT levels is a standard readout of PI3K pathway activation and is widely used to assess whether a candidate activator increases PI3K output [1,2]. This method is rapid, quantitative, and compatible with CRISPR-modified cell lines [1,2].
Lipid kinase and phosphoinositide assays
Direct measurement of PI3K catalytic activity or 3-phosphoinositide products provides biochemical evidence for activator function [1,7]. Such assays complement cell-based readouts and help distinguish activator activity from downstream pathway changes [1,7].
CRISPR screening and functional genomics
CRISPR library screening can identify genes whose loss or gain modifies PI3K-dependent phenotypes, helping to discover new activators or modifiers. This approach is particularly useful when the activator is not known a priori.
Structural and imaging approaches
Structural studies of PI3K enzymes, such as work on PI3K C2 alpha, inform how activator binding might alter enzyme conformation. Fluorescence imaging of tagged proteins can reveal where activator-PI3K interactions occur within cells.
How CRISPR Can Be Used to Study GO:0141038 phosphatidylinositol 3-kinase activator activity
Knockout
CRISPR knockout of a candidate activator gene can test whether it is required for PI3K activation and downstream phospho-AKT signaling [1,2]. Loss-of-function models are essential for distinguishing causal activators from correlative pathway components.
Point Mutation
Point-mutation models allow researchers to test whether specific residues or domains are required for the activator to bind and stimulate PI3K. Such models are particularly informative when structural data suggest a key interface.
Knock-in
Knock-in of activating or tagged variants can reveal whether a candidate gene is sufficient to increase PI3K output and whether localization matters [1,7]. Tagged knock-in also supports imaging of endogenous activator-PI3K interactions.
Overexpression
Overexpression models test gain-of-function effects and can be combined with pathway inhibitors to confirm PI3K dependence [1,8]. They are useful for screening candidate activators before more precise editing.
How EDITGENE Supports phosphatidylinositol 3-kinase activator activity Research
Researchers studying phosphatidylinositol 3-kinase activator activity-related genes often need to determine whether a candidate gene is causally involved in PI3K activation or is merely a downstream correlate. EDITGENE provides the CRISPR cell models and screening services needed to move from correlation to causal evidence in this pathway [1,2].
Contact EDITGENE today to design your custom CRISPR model for phosphatidylinositol 3-kinase activator activity research.
Frequently Asked Questions About phosphatidylinositol 3-kinase activator activity
What is phosphatidylinositol 3-kinase activator activity?
It is a molecular function, GO:0141038, in which a protein binds to and increases the activity of a phosphatidylinositol 3-kinase (PI3K).
What does GO:0141038 mean?
GO:0141038 is the Gene Ontology identifier for phosphatidylinositol 3-kinase activator activity, a molecular_function term defined by binding to and increasing PI3K activity.
What genes are involved in phosphatidylinositol 3-kinase activator activity?
Genes encoding PI3K subunits such as PIK3CA, PIK3CB, PIK3CD, PIK3C3, and PIK3C2A, as well as upstream receptors and adaptors like IGF1R, INSR, and IRS1, are central to this activity and its regulation [1,3,4,5,7].
How is phosphatidylinositol 3-kinase activator activity measured?
It is typically measured by phospho-AKT immunoblotting, lipid kinase assays, and pathway-dependent phenotypic readouts after gene perturbation [1,2,7].
Why is PI3K activator activity important in cancer?
Excessive PI3K/AKT/mTOR signaling is a common oncogenic driver, and activators that increase PI3K activity can contribute to tumor cell survival and proliferation.
What is the difference between PI3K and a PI3K activator?
PI3K is the enzyme that generates 3-phosphoinositides, while a PI3K activator is a protein that binds to PI3K and increases its catalytic activity.
Which diseases are linked to PI3K activator activity?
It has been linked to gastric cancer, corneal epithelial disorders, skeletal muscle atrophy, and hepatic glucocorticoid responses [1,2,4,5].
Can CRISPR be used to study phosphatidylinositol 3-kinase activator activity?
Yes, CRISPR knockout, point-mutation, knock-in, and overexpression models are widely used to test causal roles of candidate activators [1,2].
What pathways are downstream of PI3K activation?
The PI3K/AKT/mTOR pathway is the major downstream axis, controlling survival, proliferation, metabolism, and autophagy [1,6].
How do I choose a model to study a PI3K activator gene?
Start with knockout for requirement, then use point-mutation or knock-in for mechanism, and overexpression for sufficiency, guided by pathway readouts such as phospho-AKT [1,2].
Conclusion
GO:0141038 phosphatidylinositol 3-kinase activator activity defines a critical regulatory function that feeds into the PI3K/AKT/mTOR signaling network [1,2]. Understanding which proteins activate PI3K, how they do so, and in which disease contexts this matters requires causal experiments using CRISPR-based models and pathway-focused readouts [1,2,4,5]. As the PI3K field continues to mature, precise functional annotation of activator proteins will be essential for both mechanistic biology and therapeutic development [1,8].
References
- 1. Morgos DT et al.. 2024. Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer.. Int J Mol Sci 25(3) PMID: 38339127
- 2. Chen K et al.. 2022. The role of the PI3K/AKT signalling pathway in the corneal epithelium: recent updates.. Cell Death Dis 13(5):513 PMID: 35641491
- 3. Thiel G et al.. 2021. Insulin-Responsive Transcription Factors.. Biomolecules 11(12) PMID: 34944530
- 4. Feng L et al.. 2022. Aerobic exercise and resistance exercise alleviate skeletal muscle atrophy through IGF-1/IGF-1R-PI3K/Akt pathway in mice with myocardial infarction.. Am J Physiol Cell Physiol 322(2):C164-C176 PMID: 34852207
- 5. Shibayama Y et al.. 2022. Class 3 phosphoinositide 3-kinase promotes hepatic glucocorticoid receptor stability and transcriptional activity.. Acta Physiol (Oxf) 235(1):e13793 PMID: 35094500
- 6. Hurley JH et al.. 2017. Mechanisms of Autophagy Initiation.. Annu Rev Biochem 86:225-244 PMID: 28301741
- 7. Lo WT et al.. 2022. Structural basis of phosphatidylinositol 3-kinase C2α function.. Nat Struct Mol Biol 29(3):218-228 PMID: 35256802
- 8. Huang J et al.. 2021. Berberine Exerts Anti-cancer Activity by Modulating Adenosine Monophosphate- Activated Protein Kinase (AMPK) and the Phosphatidylinositol 3-Kinase/ Protein Kinase B (PI3K/AKT) Signaling Pathways.. Curr Pharm Des 27(4):565-574 PMID: 32988344
